Accuray (ARAY) Short-term Investments (2012 - 2026)

Accuray (ARAY) reported Short-term Investments of $467000.0 for Q1 2026, down 18.78% quarter-over-quarter from $575000.0 in Q4 2025.

Accuray (ARAY) Short-term Investments (2012 - 2026) Analysis & Trends

Accuray has reported Short-term Investments for 10 years, with the latest figure at $467000.0 in Q1 2026.

For the quarter ending Q1 2026, Short-term Investments changed N/A year-over-year to $467000.0; the trailing twelve-month figure through Mar 2026 stood at $467000.0 (changed N/A YoY), and the FY2024 full-year result was $485000.0, changed N/A from the prior year.
Short-term Investments for Q1 2026 stood at $467000.0, down from $575000.0 in the prior quarter.
The five-year high for Short-term Investments was $575000.0 in Q4 2025, with the low at $467000.0 in Q1 2026.
Historically, Short-term Investments has averaged $524750.0 across 3 years, with a median of $528500.0 in 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Accuray	41,092.55	-38.49 Mn	25.29 Mn

Download Data